Regulations.gov document
Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to…
Other · FDA-2015-D-1211 · posted May 12, 2023
Key facts
| Document ID | FDA-2015-D-1211-0361 |
|---|---|
| Title | Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2015-D-1211 |
| Posted | May 12, 2023 |
| Comment period opens | May 12, 2023 |
At a glance
- 1,000+ Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: